Published in
Elsevier, Journal of Investigative Dermatology, 4(141), p. 883-893.e6, 2021
DOI: 10.1016/j.jid.2020.08.018
Links
Tools
QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study
Journal article published in 2020 by
Olivier Bornert 
,
Marieke Hogervorst ,
Pauline Nauroy ,
Sara F. Tufa ,
Johannes Bischof ,
Jim Swildens ,
Ioannis Athanasiou ,
Douglas R. Keene ,
Tufa Sf,
Verena Wally ,
Dimitra Kiritsi ,
Eva M. Murauer ,
Keene Dr,
Stefan Hainzl ,
M. Peter Marinkovich
and other authors.
,
Marieke Hogervorst ,
Pauline Nauroy ,
Sara F. Tufa ,
Johannes Bischof ,
Jim Swildens ,
Ioannis Athanasiou ,
Douglas R. Keene ,
Tufa Sf,
Verena Wally ,
Dimitra Kiritsi ,
Eva M. Murauer ,
Keene Dr,
Stefan Hainzl ,
M. Peter Marinkovich
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 